Pain Therapeutics, Inc. PTIE-Financial and Strategic SWOT Analysis Review

Pain Therapeutics, Inc. PTIE-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH32079FSA
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pain Therapeutics, Inc. (PTIE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pain Therapeutics, Inc. (Pain Therapeutics) is a biopharmaceutical company which develops proprietary drugs for the disorders of the nervous system, such as chronic pain. The company uses patented Abuse-Deterrent Formulations or ADFs for the treatment of pain. The company's lead drug candidate, Remoxy (oxycodone) is a proprietary, abuse-deterrent, oral formulation of oxycodone (CII). Its other product candidates in development include three abuse-resistant opioid product candidates, namely, hydromorphone, hydrocodone, Fenrock and oxymorphone. The company also develops certain early stage candidates. Pain Therapeutics is headquartered in Austin, Texas, the US.

Pain Therapeutics, Inc. Key Recent Developments

May 09, 2016: Pain Therapeutics Reports 2011 Financial Results

May 05, 2016: Pain Therapeutics Reports Q1 2016 Financial Results

Mar 01, 2016: Pain Therapeutics Reports 2015 Financial Results And Corporate Update

Nov 09, 2015: Pain Therapeutics Reports Q3 2015 Financial Results and Update on REMOXY

Jul 23, 2015: Pain Therapeutics Reports Q2 2015 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Pain Therapeutics, Inc.-Key Facts 6

Pain Therapeutics, Inc.-Key Employees 7

Pain Therapeutics, Inc.-Key Employee Biographies 8

Pain Therapeutics, Inc.-Major Products and Services 9

Pain Therapeutics, Inc.-Pharmaceutical Pipeline Products Data 10

Pain Therapeutics, Inc., Pipeline Products by Therapy Area 10

Pain Therapeutics, Inc., Pipeline Products by Development Phase 11

Pain Therapeutics, Inc.-History 13

Pain Therapeutics, Inc.-Company Statement 15

Pain Therapeutics, Inc.-Locations And Subsidiaries 18

Head Office 18

Section 2-Company Analysis 19

Pain Therapeutics, Inc.-Business Description 19

Pain Therapeutics, Inc.-Corporate Strategy 20

Pain Therapeutics, Inc.-SWOT Analysis 21

SWOT Analysis-Overview 21

Pain Therapeutics, Inc.-Strengths 21

Strength-Technology 21

Strength-Lead Candidate: Remoxy 21

Strength-Research and Development 21

Pain Therapeutics, Inc.-Weaknesses 22

Weakness-Lack of Marketed Products 22

Weakness-Higher Cost Structure 22

Pain Therapeutics, Inc.-Opportunities 23

Opportunity-Changing Demographics 23

Opportunity-Rising Healthcare Expenditure in the US 23

Opportunity-Market Potential: Pain Management 23

Pain Therapeutics, Inc.-Threats 24

Threat-Reliance on Third Parties 24

Threat-Patent Expiries 24

Threat-Intense Competition 24

Pain Therapeutics, Inc.-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Recent Developments 31

May 09, 2016: Pain Therapeutics Reports 2011 Financial Results 31

May 05, 2016: Pain Therapeutics Reports Q1 2016 Financial Results 32

Mar 01, 2016: Pain Therapeutics Reports 2015 Financial Results And Corporate Update 33

Nov 09, 2015: Pain Therapeutics Reports Q3 2015 Financial Results and Update on REMOXY 35

Jul 23, 2015: Pain Therapeutics Reports Q2 2015 Financial Results 37

May 11, 2015: Pain Therapeutics Announces Update on Drug Portfolio 38

May 07, 2015: Pain Therapeutics Reports Q1 2015 Financial Results 40

Apr 23, 2015: Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs 41

Feb 17, 2015: Pain Therapeutics Reports FY 2014 Financial Results 42

Section 5-Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

Pain Therapeutics, Inc., Pipeline Products by Therapy Area 10

Pain Therapeutics, Inc., Pipeline Products by Development Phase 11

Pain Therapeutics, Inc., Performance Chart (2011-2015) 28

Pain Therapeutics, Inc., Ratio Charts 30

List of Tables

Pain Therapeutics, Inc., Key Facts 6

Pain Therapeutics, Inc., Key Employees 7

Pain Therapeutics, Inc., Key Employee Biographies 8

Pain Therapeutics, Inc., Major Products and Services 9

Pain Therapeutics, Inc., Number of Pipeline Products by Therapy Area 10

Pain Therapeutics, Inc., Number of Pipeline Products by Development Stage 11

Pain Therapeutics, Inc., Pipeline Products By Therapy Area and Development Phase 12

Pain Therapeutics, Inc., History 13

Pain Therapeutics, Inc., Key Competitors 25

Pain Therapeutics, Inc., Ratios based on current share price 26

Pain Therapeutics, Inc., Annual Ratios 27

Pain Therapeutics, Inc., Interim Ratios 29

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Roxane Laboratories, Inc.

Purdue Pharma L.P.

Endo Pharmaceuticals Inc.

Elkins-Sinn Inc

Alternative technologies

Pain Therapeutics, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com